Nephosity

Los Angeles, California, United States

Medical Imaging Imaging Diagnostics Clinical Workflow Interoperability

Nephosity builds the platform for collaborative medical imaging, enabling anywhere, anytime viewing, sharing, and collaboration of patient cases involving medical imaging. This optimizes the medical imaging workflow for physicians and other healthcare providers, which lowers costs, engages patients, and improves care.. Imaging is at the heart of medicine today, but the workflows involved with medical imaging leads to many inefficiencies. Collaborative medical imaging improves care in various scenarios, e.g. when. * the ER doctor needs to consult the radiologist about the finding. * an ambulance transfers a patient from one hospital to another, but CDs of the patient’s images on stretcher with patient. * doctors form a tumor board to discuss a case. * insurers want to review patient images before approving treatment. * a patient wants a second opinion but needs to drive a couple hours to visit the closest specialist. MobileCT Viewer is Nephosity's medical image viewer for the iPad. It has received the FDA 510(k) clearance.. Jack Imaging is the anywhere, anytime platform for medical image viewing, sharing, and collaboration. Visit http://jackimaging.com for more information and to request an invite.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out Nephosity on @MedStartr Today #MedicalImaging #Diagnostics #Radiology #ImagingDiagnostics #ClinicalWorkflow #Interoperability #MedMo #MedStartrVentures

https://www.medstartr.ai/s/j8kR_mzY7n0

Get Involved in Nephosity

Company Info

Founded: 2011
Website: nephosity.com

Disease Areas

Medical Imaging Diagnostics Radiology

Technologies

Medical ImagingPlatformImage ExchangeCloud-Based Platform

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of Nephosity?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.